Chinese Glioma Genome Atlas (CGGA): a comprehensive resource with functional genomic data from Chinese glioma patients Z Zhao, KN Zhang, Q Wang, G Li, F Zeng, Y Zhang, F Wu, R Chai, Z Wang, ... Genomics, Proteomics and Bioinformatics 19 (1), 1-12, 2021 | 595 | 2021 |
Mutational landscape of secondary glioblastoma guides MET-targeted trial in brain tumor H Hu, Q Mu, Z Bao, Y Chen, Y Liu, J Chen, K Wang, Z Wang, Y Nam, ... Cell 175 (6), 1665-1678. e18, 2018 | 273 | 2018 |
circRNA disease: a manually curated database of experimentally supported circRNA-disease associations Z Zhao, K Wang, F Wu, W Wang, K Zhang, H Hu, Y Liu, T Jiang Cell death & disease 9 (5), 475, 2018 | 193 | 2018 |
m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas RC Chai, F Wu, QX Wang, S Zhang, KN Zhang, YQ Liu, Z Zhao, T Jiang, ... Aging (Albany NY) 11 (4), 1204, 2019 | 179 | 2019 |
An immune-related lncRNA signature for patients with anaplastic gliomas W Wang, Z Zhao, F Yang, H Wang, F Wu, T Liang, X Yan, J Li, Q Lan, ... Journal of neuro-oncology 136, 263-271, 2018 | 133 | 2018 |
An MRI radiomics approach to predict survival and tumour-infiltrating macrophages in gliomas G Li, L Li, Y Li, Z Qian, F Wu, Y He, H Jiang, R Li, D Wang, Y Zhai, Z Wang, ... Brain 145 (3), 1151-1161, 2022 | 125 | 2022 |
Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples G Li, Z Wang, C Zhang, X Liu, J Cai, Z Wang, H Hu, F Wu, Z Bao, Y Liu, ... Oncoimmunology 6 (8), e1328339, 2017 | 120 | 2017 |
Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies K Yu, Y Hu, F Wu, Q Guo, Z Qian, W Hu, J Chen, K Wang, X Fan, X Wu, ... National science review 7 (8), 1306-1318, 2020 | 107 | 2020 |
Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma F Wu, C Zhang, J Cai, F Yang, T Liang, X Yan, H Wang, W Wang, J Chen, ... Oncotarget 8 (32), 53110, 2017 | 71 | 2017 |
LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas W Wang, F Yang, L Zhang, J Chen, Z Zhao, H Wang, F Wu, T Liang, ... Oncotarget 7 (47), 77225, 2016 | 71 | 2016 |
Prognostic power of a lipid metabolism gene panel for diffuse gliomas F Wu, Z Zhao, RC Chai, YQ Liu, GZ Li, HY Jiang, T Jiang Journal of cellular and molecular medicine 23 (11), 7741-7748, 2019 | 63 | 2019 |
Acidosis enhances the self-renewal and mitochondrial respiration of stem cell-like glioma cells through CYP24A1-mediated reduction of vitamin D P Hu, S Li, N Tian, F Wu, Y Hu, D Li, Y Qi, Z Wei, Q Wei, Y Li, B Yin, ... Cell Death & Disease 10 (1), 25, 2019 | 62 | 2019 |
Identification of an energy metabolism-related signature associated with clinical prognosis in diffuse glioma Z Zhou, R Huang, R Chai, X Zhou, Z Hu, W Wang, B Chen, L Deng, Y Liu, ... Aging (Albany NY) 10 (11), 3185, 2018 | 53 | 2018 |
The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13 Y Hu, M Zhang, N Tian, D Li, F Wu, P Hu, Z Wang, L Wang, W Hao, ... The Journal of clinical investigation 129 (8), 3072-3085, 2019 | 51 | 2019 |
Classification of diffuse lower‐grade glioma based on immunological profiling F Wu, ZL Wang, KY Wang, GZ Li, RC Chai, YQ Liu, HY Jiang, Y Zhai, ... Molecular Oncology 14 (9), 2081-2095, 2020 | 49 | 2020 |
Molecular subtyping reveals immune alterations in IDH wild‐type lower‐grade diffuse glioma F Wu, GZ Li, HJ Liu, Z Zhao, RC Chai, YQ Liu, HY Jiang, Y Zhai, YM Feng, ... The Journal of pathology 251 (3), 272-283, 2020 | 47 | 2020 |
Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma RC Chai, KN Zhang, YZ Chang, F Wu, YQ Liu, Z Zhao, KY Wang, ... Carcinogenesis 40 (10), 1229-1239, 2019 | 47 | 2019 |
Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma R Chai, G Li, Y Liu, K Zhang, Z Zhao, F Wu, Y Chang, B Pang, J Li, Y Li, ... Cancer Biology & Medicine 18 (1), 271, 2021 | 46 | 2021 |
Amino acid metabolism‐related gene expression‐based risk signature can better predict overall survival for glioma YQ Liu, RC Chai, YZ Wang, Z Wang, X Liu, F Wu, T Jiang Cancer science 110 (1), 321-333, 2019 | 44 | 2019 |
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples W Di, W Fan, F Wu, Z Shi, Z Wang, M Yu, Y Zhai, Y Chang, C Pan, G Li, ... Cancer science 113 (2), 756-769, 2022 | 43 | 2022 |